Massive MGUS screening aims to unlock early myeloma clues
NCT ID NCT06472830
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This study screens 1000 adults aged 40 and older for MGUS, a condition with an abnormal blood protein that can sometimes lead to multiple myeloma. Researchers want to learn about genetic and immune factors behind MGUS, especially in diverse populations. The goal is to improve early detection and future care for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene clues may unlock new treatments for bone marrow cancer
- New blood test screening targets hidden cancer in black communities
- Gut bacteria drug shows promise against blood disorder
- Turmeric and black pepper extract shows promise in slowing early cancers
- 1,000 volunteers help scientists unlock the mystery of myeloma progression
- New italian network aims to catch rare blood disease earlier